Press "esc" to clear
Go to Advanced Search

Showing results

1120 of 231
bsquare-300x300.jpg

Article ID: 691734

Researchers Identify Chemical Compound That Inhibits Ebola Virus Replication

Georgia State University

An organic chemical compound shows effective antiviral activity against Ebola virus and several other viruses, according to a study led by Georgia State University.

Released:
26-Mar-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
GGH_6168.JPG
  • Embargo expired:
    22-Feb-2018 9:30 AM EST

Article ID: 689866

Promising Treatment for Ebola Virus to be Tested at Texas Biomed

Texas Biomedical Research Institute

During the West African Ebola outbreak that began in 2013, an experimental biopharmaceutical drug called ZMappTM was a glimmer of hope in the midst of a health crisis. Now, scientists at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic.

Released:
20-Feb-2018 4:15 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
andersen_kristian.jpg

Article ID: 689655

TSRI Scientists Receive $15 Million to Study Viral Outbreak Survivors

Scripps Research Institute

The researchers will spend the next five years collecting data from Ebola and Lassa survivors to learn how they fought off the virus.

Released:
15-Feb-2018 5:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Marburg_structure.jpg
  • Embargo expired:
    10-Jan-2018 12:00 PM EST

Article ID: 687718

TSRI Scientists Discover Workings of First Promising Marburg Virus Treatment

Scripps Research Institute

Scientists at The Scripps Research Institute have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus.

Released:
9-Jan-2018 5:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Ebolavirusresearcher-NicoleHoff.jpg

Article ID: 686837

40 Years After First Ebola Outbreak, Survivors Show Signs They Can Stave Off New Infection

University of California, Los Angeles (UCLA), Health Sciences

Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks

Released:
14-Dec-2017 12:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Kawaoka-Sierra-Leone-8.jpg

Article ID: 685385

Unlocking the Secrets of Ebola

Pacific Northwest National Laboratory

Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease. The results come from one of the most in-depth studies ever of blood samples from patients with Ebola.

Released:
16-Nov-2017 4:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Ebolavial.JPG
  • Embargo expired:
    16-Nov-2017 12:00 PM EST

Article ID: 685218

In the Heart of Devastating Outbreak, Research Team Unlocks Secrets of Ebola

University of Wisconsin-Madison

In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin–Madison has identified signatures of Ebola virus disease that may aid in future treatment efforts.

Released:
14-Nov-2017 4:30 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
nrhd-logo2017.png
  • Embargo expired:
    8-Nov-2017 8:55 AM EST

Article ID: 684299

Closing the Rural Health Gap: Media Update from RWJF and Partners on Rural Health Disparities

Newswise

Rural counties continue to rank lowest among counties across the U.S., in terms of health outcomes. A group of national organizations including the Robert Wood Johnson Foundation and the National 4-H Council are leading the way to close the rural health gap.

Released:
8-Nov-2017 8:55 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Law and Public Policy

Article ID: 682041

Researchers Identify Protein That Could Reduce Death, Improve Symptoms In Influenza and Other Infectious Diseases

University of Maryland School of Medicine

A new study by researchers has identified an innovative strategy for treating influenza, and perhaps other infectious diseases as well. Scientists showed that a small protein called retrocyclin-101 (RC-101) could potentially improve the symptoms and mortality associated with the flu and possibly other types of infectious illness as well.

Released:
29-Sep-2017 4:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 681870

Novel Vaccine for Ebola and other Hemorrhagic Fever Viruses

Thomas Jefferson University

A collaboration among research institutions, private industry, and the US Government will develop a tetravalent vaccine to protect against four viruses that can be fatal

Released:
27-Sep-2017 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

1120 of 231





Chat now!